Fig. 4From: Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort studyLiver tumor burden and time-to-new treatment. Relation between liver tumor burden and time-to-new treatmentBack to article page